Nvidia Introduces RTX 50 Series Graphics Chips at CES 2025
January 7, 2025 - 02:06
Nvidia has officially launched its highly anticipated RTX 50 series of graphics chips during the CES 2025 event. This new lineup includes a range of powerful desktop and laptop graphics cards, with the flagship model, the RTX 5090, priced at $1,999.
The RTX 50 series promises significant advancements in gaming performance, featuring cutting-edge technology that enhances ray tracing capabilities and overall rendering quality. Gamers can expect smoother frame rates and more immersive experiences, thanks to the improved architecture and increased processing power of these new chips.
In addition to the RTX 5090, Nvidia has introduced several other models in the series, catering to a variety of gaming needs and budgets. The company emphasizes its commitment to pushing the boundaries of graphics technology, aiming to meet the demands of both casual and professional gamers alike. As the gaming landscape continues to evolve, Nvidia's RTX 50 series is poised to set new standards in visual fidelity and performance.
MORE NEWS
June 23, 2026 - 20:50
Bitcoin 'vulnerable to further weakness' as token tumbles amid tech routBitcoin took a sharp hit on Tuesday, falling in tandem with a broad sell-off in technology stocks that rattled global markets. The leading cryptocurrency dropped more than 5% in a single session,...
June 23, 2026 - 18:40
SpaceX stock dips below $150 debut before reboundingSpaceX`s stock took another hit on Tuesday, sliding below its initial public offering price of $150 before recovering later in the session. The sell-off extended a rough stretch for the company`s...
June 22, 2026 - 17:54
SpaceX stock tumbles 16.4%, shaving off most IPO gains since debutSpaceX shares took another sharp hit on Monday, putting the company on track for three consecutive days of losses. The steep decline has wiped out the majority of the gains the stock had racked up...
June 22, 2026 - 04:41
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth NarrativeWest Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation...